| Primary |
| Drug Use For Unknown Indication |
21.3% |
| Colorectal Cancer Metastatic |
9.9% |
| Colon Cancer |
8.5% |
| Product Used For Unknown Indication |
8.4% |
| Colorectal Cancer |
6.9% |
| Colon Cancer Metastatic |
6.1% |
| Breast Cancer |
6.1% |
| Non-small Cell Lung Cancer |
5.4% |
| Breast Cancer Metastatic |
3.9% |
| Macular Degeneration |
2.9% |
| Lung Neoplasm Malignant |
2.9% |
| Ovarian Cancer |
2.7% |
| Rectal Cancer |
2.5% |
| Large Intestine Carcinoma |
2.1% |
| Rectal Cancer Metastatic |
2.1% |
| Glioblastoma |
1.9% |
| Lung Adenocarcinoma |
1.8% |
| Brain Neoplasm Malignant |
1.6% |
| Breast Cancer Female |
1.5% |
| Lung Adenocarcinoma Metastatic |
1.4% |
|
| Death |
55.7% |
| Disease Progression |
12.1% |
| Vomiting |
4.6% |
| Pyrexia |
2.6% |
| Interstitial Lung Disease |
2.2% |
| Endophthalmitis |
2.2% |
| Malignant Neoplasm Progression |
1.8% |
| Hypertension |
1.8% |
| Uveitis |
1.8% |
| Pulmonary Embolism |
1.7% |
| White Blood Cell Count Decreased |
1.7% |
| Renal Failure |
1.5% |
| Sepsis |
1.4% |
| Visual Acuity Reduced |
1.4% |
| Weight Decreased |
1.3% |
| Renal Failure Acute |
1.3% |
| Thrombocytopenia |
1.3% |
| Pneumonia |
1.3% |
| Pneumothorax |
1.2% |
| Proteinuria |
1.2% |
|
| Secondary |
| Colon Cancer Metastatic |
11.3% |
| Colon Cancer |
10.4% |
| Product Used For Unknown Indication |
8.9% |
| Drug Use For Unknown Indication |
7.6% |
| Breast Cancer |
7.5% |
| Colorectal Cancer Metastatic |
6.1% |
| Rectal Cancer Metastatic |
5.7% |
| Colorectal Cancer |
5.7% |
| Rectal Cancer |
5.5% |
| Non-small Cell Lung Cancer |
4.4% |
| Breast Cancer Metastatic |
3.3% |
| Premedication |
3.3% |
| Lung Neoplasm Malignant |
3.2% |
| Metastatic Renal Cell Carcinoma |
2.8% |
| Large Intestine Carcinoma |
2.7% |
| Macular Degeneration |
2.4% |
| Hypertension |
2.4% |
| Glioblastoma |
2.3% |
| Colon Cancer Recurrent |
2.3% |
| Ovarian Cancer |
2.1% |
|
| Death |
39.5% |
| Vomiting |
10.1% |
| Disease Progression |
8.0% |
| Weight Decreased |
4.9% |
| White Blood Cell Count Decreased |
3.2% |
| Stomatitis |
2.8% |
| Gastrointestinal Perforation |
2.8% |
| Pyrexia |
2.8% |
| Nausea |
2.6% |
| Pulmonary Embolism |
2.5% |
| Visual Acuity Reduced |
2.5% |
| Wound Dehiscence |
2.3% |
| Rash |
2.2% |
| Thrombocytopenia |
2.0% |
| Hypertension |
2.0% |
| Pain |
2.0% |
| Sepsis |
2.0% |
| Renal Failure Acute |
2.0% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
1.8% |
| Interstitial Lung Disease |
1.8% |
|
| Concomitant |
| Colon Cancer |
18.0% |
| Product Used For Unknown Indication |
10.0% |
| Non-small Cell Lung Cancer |
8.7% |
| Metastases To Bone |
6.8% |
| Breast Cancer Metastatic |
6.7% |
| Colorectal Cancer |
6.5% |
| Breast Cancer |
6.4% |
| Premedication |
5.3% |
| Rectal Cancer |
4.6% |
| Drug Use For Unknown Indication |
3.9% |
| Colon Cancer Metastatic |
3.6% |
| Pain |
2.9% |
| Hypertension |
2.6% |
| Lung Neoplasm Malignant |
2.5% |
| Nausea |
2.3% |
| Prophylaxis |
2.2% |
| Colorectal Cancer Metastatic |
2.1% |
| Chemotherapy |
2.1% |
| Large Intestine Carcinoma |
1.4% |
| Lung Adenocarcinoma |
1.4% |
|
| Vomiting |
11.6% |
| Weight Decreased |
9.4% |
| White Blood Cell Count Decreased |
8.2% |
| Toothache |
6.9% |
| Death |
6.3% |
| Osteonecrosis Of Jaw |
5.8% |
| Pyrexia |
5.2% |
| Tooth Extraction |
5.0% |
| Rash |
4.7% |
| Thrombocytopenia |
4.6% |
| Osteonecrosis |
4.4% |
| Pulmonary Embolism |
3.5% |
| Wound Dehiscence |
3.5% |
| Diarrhoea |
3.1% |
| Pain In Jaw |
3.1% |
| Fatigue |
3.0% |
| Nausea |
3.0% |
| Platelet Count Decreased |
3.0% |
| Dyspnoea |
2.8% |
| Pain In Extremity |
2.8% |
|
| Interacting |
| Breast Cancer Metastatic |
19.0% |
| Hiv Infection |
17.9% |
| Breast Cancer |
9.5% |
| Product Used For Unknown Indication |
9.5% |
| Drug Use For Unknown Indication |
8.3% |
| Metastases To Bone |
7.1% |
| Colon Cancer |
3.6% |
| Ovarian Epithelial Cancer |
3.6% |
| Brain Neoplasm Malignant |
2.4% |
| Colorectal Cancer |
2.4% |
| Lung Adenocarcinoma |
2.4% |
| Macular Degeneration |
2.4% |
| Metastases To Pleura |
2.4% |
| Premedication |
2.4% |
| Acne |
1.2% |
| Depression |
1.2% |
| Epilepsy |
1.2% |
| Lung Neoplasm Malignant |
1.2% |
| Off Label Use |
1.2% |
| Renal Cell Carcinoma |
1.2% |
|
| Gastrointestinal Carcinoma |
18.5% |
| Drug Interaction |
14.8% |
| Ischaemic Stroke |
11.1% |
| Hypertension |
7.4% |
| Mucosal Inflammation |
7.4% |
| Osteonecrosis |
7.4% |
| Swelling |
7.4% |
| Flank Pain |
3.7% |
| Jaundice |
3.7% |
| Lethargy |
3.7% |
| Pancytopenia |
3.7% |
| Paralysis |
3.7% |
| Parkinson's Disease |
3.7% |
| Tachycardia |
3.7% |
|
